Prostatitis: US perspective

A. J. Schaeffer*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

57 Scopus citations


The diagnosis and management of prostatitis syndromes is a challenge to the clinician. Careful history and examination of the prostate fluid and quantitative segmented bacteriologic cultures will lead to proper categorization into the recognized forms of the prostatitis syndrome. Antimicrobial therapy is effective in the majority of men with acute and chronic bacterial prostatitis (CBP). Fluoroquinolone agents appear to have an increasingly important role in this regard, although a randomized, prospective, double-blind study is still lacking. Alpha-1-selective blocking agents may relieve symptomatology of chronic pelvis pain syndrome (CPPS). Other non-prostatic sources of voiding symptoms should be sought and ruled out, especially malignancy or inflammatory disorders. Copyright (C) 1999 Elsevier Science B.V.

Original languageEnglish (US)
Pages (from-to)205-211
Number of pages7
JournalInternational Journal of Antimicrobial Agents
Issue number3-4
StatePublished - May 1999


  • Pelvic pain
  • Prostatitis
  • Urinary tract infection

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases
  • Pharmacology (medical)


Dive into the research topics of 'Prostatitis: US perspective'. Together they form a unique fingerprint.

Cite this